000 02282 a2200625 4500
005 20250515203549.0
264 0 _c20100421
008 201004s 0 0 eng d
022 _a1537-6591
024 7 _a10.1086/650002
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSteigbigel, Roy T
245 0 0 _aLong-term efficacy and safety of Raltegravir combined with optimized background therapy in treatment-experienced patients with drug-resistant HIV infection: week 96 results of the BENCHMRK 1 and 2 Phase III trials.
_h[electronic resource]
260 _bClinical infectious diseases : an official publication of the Infectious Diseases Society of America
_cFeb 2010
300 _a605-12 p.
_bdigital
500 _aPublication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 0 4 _aAnti-HIV Agents
_xadverse effects
650 0 4 _aCD4 Lymphocyte Count
650 0 4 _aDouble-Blind Method
650 0 4 _aDrug Resistance, Viral
650 0 4 _aDrug Therapy, Combination
650 0 4 _aFemale
650 0 4 _aHIV Infections
_xdrug therapy
650 0 4 _aHIV-1
_xdrug effects
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPyrrolidinones
_xadverse effects
650 0 4 _aRNA, Viral
_xblood
650 0 4 _aRaltegravir Potassium
650 0 4 _aViral Load
700 1 _aCooper, David A
700 1 _aTeppler, Hedy
700 1 _aEron, Joseph J
700 1 _aGatell, Jose M
700 1 _aKumar, Princy N
700 1 _aRockstroh, Jurgen K
700 1 _aSchechter, Mauro
700 1 _aKatlama, Christine
700 1 _aMarkowitz, Martin
700 1 _aYeni, Patrick
700 1 _aLoutfy, Mona R
700 1 _aLazzarin, Adriano
700 1 _aLennox, Jeffrey L
700 1 _aClotet, Bonaventura
700 1 _aZhao, Jing
700 1 _aWan, Hong
700 1 _aRhodes, Rand R
700 1 _aStrohmaier, Kim M
700 1 _aBarnard, Richard J
700 1 _aIsaacs, Robin D
700 1 _aNguyen, Bach-Yen T
773 0 _tClinical infectious diseases : an official publication of the Infectious Diseases Society of America
_gvol. 50
_gno. 4
_gp. 605-12
856 4 0 _uhttps://doi.org/10.1086/650002
_zAvailable from publisher's website
999 _c19462466
_d19462466